Mark P Rubinstein, PhD Ohio State cancer researcher

Mark P Rubinstein, PhD, is a Translational Therapeutics research program member at the OSUCCC – James. Learn more

Immunotherapeutic HCW9218 augments anti-tumor activity of

Lab Members

Karen Mohlke, PhD and Victor Garcia-Martinez, PhD named Smithies

Clinical characteristics, racial inequities, and outcomes in

Department of History Faculty - Weissman School of Arts and Sciences

Mark P. Rubinstein's research works

Joseph Azar (@JosephHalimAzar) / X

Translational Therapeutics Research Program Members

Ohio State Study Reveals Drivers of Immune Evasion, Cancer

2020 Education & Research Fund Annual Report by AAPM Docs - Issuu

Mark P. Rubinstein's research works

Immunotherapy: Programming Your Immune System to Target Cancer

Mark P. Rubinstein's research works

UNC Men's Basketball Coach Roy Williams Speaks to Medicine

Home